Promedior, Inc.   Report issue

For profit Phase 2
Founded: Lexington MA United States (2006)
Status: Acquired by Roche (2019)

Organization Overview

First Clinical Trial
2010
NCT01064817
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree